Each option represents a different level of heart failure treatment, and not every patient requires invasive intervention. The goal is always to match the intensity of treatment with the severity of the disease.
For many patients, treatment begins with what is called guideline-directed medical therapy. Modern drug therapy has changed the outlook of heart failure dramatically. Such therapies may include:
● ACE inhibitors or ARNI (sacubitril/valsartan)
● Beta blockers
● Mineralocorticoid receptor antagonists
● SGLT2 inhibitors
● Diuretics for fluid control
If suitable for the concern, these medications can effectively:
● Reduce strain on the heart
● Remove excess fluid
● Improve long-term survival
● Decrease hospital admissions
Specialised centres abroad closely monitor dosage adjustments, especially in the early weeks. This close supervision is particularly helpful for overseas patients who may need stabilisation before travelling back home.
When medication is not enough, device therapy may be considered. Accordingly, some patients remain at risk of dangerous arrhythmias or persistent heart weakness despite medication.
In these cases:
● Implantable Cardioverter-Defibrillators (ICDs) reduce the risk of sudden cardiac death.
● Cardiac Resynchronisation Therapy (CRT) improves coordination between heart chambers in patients with electrical conduction delays.
Eligibility for these devices depends on ejection fraction, QRS duration on ECG, and symptom severity. These forms of heart failure treatment do not cure the condition, but they significantly reduce complications in selected patients. Most procedures involve a short hospital stay and careful programming before discharge.
In some patients, heart failure is a result of blocked arteries or severe valve disease. In such cases, correcting the root issue is the ideal treatment to improve heart function.
Options may include:
● Angioplasty or bypass surgery to restore the blood supply
● Minimally invasive valve repair or replacement
● Hybrid procedures combining interventional cardiology and surgery
For individuals with severe disease, mechanical circulatory support such as a ventricular assist device may be recommended. These are complex decisions made within experienced advanced cardiac care teams.
Despite extensive treatment and medication, the patient may reach a point when oral medication or other treatments are deemed insufficient.
Ventricular Assist Devices (VAD)
A VAD is a mechanical pump that helps circulate blood. It may serve as:
● A bridge to transplant, or
● Long-term therapy in selected patients
Risks include infection, bleeding, stroke, and device malfunction. Recovery requires close monitoring.
A transplant is reserved for those patients who have reached the end-stage of the disease, and no treatments or even VAD will be effective for them.
It requires:
● Extensive evaluation
● Psychological assessment
● Long-term commitment to follow-up
● Lifelong immunosuppressive medication
While transplantation can dramatically improve quality of life, it also carries risks such as rejection and infection.
Travelling for heart failure treatment involves more than medical preparation.
Important considerations include:
● Fitness to fly
● Duration of stay
● Accommodation for the accompanying family
● Insurance and financial planning
● Post-treatment follow-up coordination
Many leading centres provide international patient coordinators who assist with documentation, appointments, and communication with home-country physicians. This support eases practical burdens during an already stressful time.
Even after advanced procedures, management does not end.
Long-term care often includes:
● Structured cardiac rehabilitation
● Weight and symptom monitoring
● Dietary adjustments
● Gradual physical conditioning
● Emotional and psychological support
Sustainable improvement depends on a partnership between the patient and the medical team. Procedures can stabilise or improve heart function, but daily habits remain central to long-term success.
Heart failure is a serious condition, but it is no longer a hopeless one. With modern heart failure treatment, patients have access to a wide spectrum of therapies ranging from medication optimisation to sophisticated surgical interventions. For international patients, seeking advanced cardiac care abroad can open doors to specialised expertise and comprehensive management.
If you are considering heart failure treatment options outside your home country, begin with a detailed medical consultation at the Manipal Hospitals network. A personalised assessment will help determine which pathway offers the safest and most effective route towards stabilisation and improved quality of life.